|
|
Active Org.- |
|
|
|
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.RU |
First Approval Date30 Jun 2017 |
|
MechanismDNA polymerase inhibitors [+1] |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
Mechanismneuraminidase inhibitors |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Viriom Ltd.
0 Patents (Medical) associated with Viriom Ltd.
100 Deals associated with Viriom Ltd.
100 Translational Medicine associated with Viriom Ltd.